Top Tech Companies in San Francisco Bay Area, CA (10,000+)
Keplar is an AI-native market research platform designed to enable companies to make better, faster decisions with customer obsession. We leverage advanced, human-level conversational tech, behavioral simulation, and deep agentic market research.
Ally Software is changing the way groups and teams collaborate. Our solutions emphasize communication over document management, and transparency over strict lines of communication. Ally Software was started by a former product manager who had a vision for helping groups, teams, management, and partners communicate and execute better. By breaking down barriers and creating shared spaces, we're helping companies get better...
At Lully, we’re building the children’s sleep company. We create innovative, thoughtfully-designed, clinically-proven consumer products to help children, and their families, sleep better. Our first product, The Sleep Guardian is the only solution for night terrors. Based on our patented, clinically-proven technology, the Sleep Guardian goes under t
Munchery is dedicated to making real food, on your terms. Our mission is to make real food the easy, accessible choice for people who want delicious and healthy meals. You shouldn’t have to compromise between food that tastes good and food that’s good for your health. Our award-winning chefs create high-quality dishes from scratch using wholesome ingredients. We source seasonal ingredients...
Skyline Advanced Technology Services (ATS) is a leading provider of technology, education, professional services and solutions since 1989. We accelerate business initiatives and enhance customer experiences by providing superior education, solutions, services, and support to help affect positive business transformation.
A.N. Publishing is a beacon of intellectualism with well-researched topics and in-depth features in an otherwise vacuous environment of sensationalized headlines and specious information. Committed to delivering thoughtful and engaging content for the sophisticated contemporary reader, A.N. Publishing’s brands reflect a diverse array of voices. A.N. Publishing’s lifestyle brands target young professionals through generationally focused content. Man of the Hour...
Understand your genome. Help cure diseases. Own your data. Powered by blockchain.
UFP Industries is a holding company whose operating subsidiaries – UFP Packaging, UFP Construction and UFP Retail Solutions – manufacture, distribute and sell a wide variety of products used in residential and commercial construction, packaging and industrial applications. Founded in 1955, the company has operations in North America, Europe, Asia and Australia.
UFP Industries's Top Stability & Growth Strengths
Strong Market Position & Advantage: UFP is recognized as the world’s largest pressure treater and a scale leader in U.S. industrial wood packaging with a nationwide, company-owned footprint. A broad multi-segment platform and global network underpin competitive reach across retail, construction, and packaging.
Investor Backing & Capital Strength: The balance sheet shows substantial cash and liquidity, providing flexibility for investments, buybacks, and dividends. This financial strength supports resilience through cyclical slowdowns and competitive pricing environments.
Future-Ready Strategy: Management is executing significant multi-year investments in automation, technology, and expansion while shifting mix toward value-added products. These initiatives aim to drive share gains, operational efficiency, and margin compounding over time.
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 leverages recent advances in human genetics, combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms, to advance therapeutics for devastating diseases. The Company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases....
Our mission is to empower all startup employees to participate in the success of the companies they helped build. We do so by linking employees to accredited investors, who compete to provide them with the funding they need to exercise their stock options. Our platform allows employees to minimize the downside risk associated with exercising their options, while giving investors...
Zetta invests in intelligent enterprise software. We partner with companies building software that learns from data to analyze, predict and prescribe outcomes. We lead or co-lead $1-5M funding rounds.
We believe experience matters. Founded in 1979, GMR is an innovative global sponsorship and experiential leader, connecting brands and their consumers through shared passions. We change how people think, feel and behave through the power of experience. Experiences founded on data, rooted in insight, grounded in strategy, designed meticulously and executed flawlessly. Our passionate global team creates, consults and activates...
Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab, is a novel Azymetric™ HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials...
FOUNDER.org is an investor and company building program for student entrepreneurs at leading universities around the world. Our intense, 8D© Company Building Program fast tracks your team through the challenges of building a high impact company, while you’re doing it. And we provide you with the funding you need to get started. Our hands-on, transformative, experience is designed to increase...
We’re a health care opportunity company, tackling the problems others don’t, won’t or can’t. Where some see obstacles, we see possibilities. At Express Scripts, we dare to imagine a better health care system, and we’re driven to make it happen. We’re challengers, difference-makers and opportunity-seekers, united with our partners in pursuit of a simpler, more sustainable system and better health...
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline includes two investigational oral SYK inhibitors, entospletinib and lanraplenib, which are being developed to treat acute myeloid leukemia (AML). Together the compounds have the potential to target mutations present in more than two-thirds of patients with AML....
Hortonworks is an industry leading innovator that creates, distributes and supports enterprise-ready open data platforms and modern data applications that deliver actionable intelligence from all data: data-in-motion and data-at-rest. Hortonworks is focused on driving innovation in open source communities such as Apache Hadoop, NiFi and Spark. Along with its 1,600+ partners, Hortonworks provides the expertise, training and services that allow...
Neuromation is a leading Enterprise AI solutions and platform provider recently recognized by Gartner as a "Cool Vendors in AI Core Technologies." The company's Neuro platform is a best-in-class machine learning development tool enabling rapid model iteration with an unparalleled developer experience.
Collective Health is a technology company simplifying employer healthcare to make health insurance work for everyone. With more than a quarter million members and over 60 enterprise clients—including Pinterest, Restoration Hardware, and more—our technical and customer experience teams are reinventing the healthcare experience for employers and their people.
Collective Health's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Materials describe substantial multi-round funding with prominent investors and sustained high valuation references, signaling strong capital support. This suggests available resources to invest in platform development, partnerships, and expansion.
Market Expansion: Information points to rising membership, added enterprise clients, expanded state and network coverage, and new offices. These moves indicate growing geographic reach and distribution channels.
Strategic Partnerships: The company has broadened its ecosystem and secured notable health-plan and network collaborations, including platform-powered arrangements with regional and national payers. Such alliances appear to enhance distribution, credibility, and access to larger employer populations.
